iShares Trust iShares Large Cap Max Buffer Jun ETF (BATS: MAXJ)

Latest news for iShares Trust iShares Large Cap Max Buffer Jun ETF (BATS:MAXJ)

The Fund seeks to provide exposure to the share price return of the Underlying ETF up to an approximate upside limit (the Approximate Cap), while seeking to maximize the downside protection against Underlying ETF losses (the Approximate Buffer) over each annual Hedge Period (as defined below)

iShares Large Cap Max Buffer Jun ETF

iShares Trust iShares Large Cap Max Buffer Jun ETF

WIIM

CVRX

CVRx shares are trading higher after William Blair upgraded the stock from Market Perform to Outperform.

<p>Piper Sandler  analyst David Amsellem   downgrades Intra-Cellular Therapies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITCI#NASDAQ">ITCI</a>) from Overweight to Neutral and raises the price target from $107 to $132.</p>


News

Downgrades

Price Target

Analyst Ratings

ITCI

Piper Sandler Downgrades Intra-Cellular Therapies to Neutral, Raises Price Target to $132

CLMT

Calumet shares are trading lower after the company reported preliminary Q4 financial results.

<p>Genter Capital launched two new dividend-focused ETFs on Jan. 13 — the <strong>Genter Capital Dividend Income ETF </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEND#NYSE">GEND</a>) and the <strong>Genter Capital International Dividend ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GENW#NYSE">GENW</a>). These funds aim to provide investors with opportunities for <a href="https://www.benzinga.com/topic/etf">income and growth</a>, leveraging Genter Capital&#8217;s expertise in market management.</p>
<p><strong>Also Read: <a href="https://www.benzinga.com/etfs/new-etfs/25/01/42916986/allianzim-pioneers-risk-managed-investment-launches-two-laddered-buffer-etfs">AllianzIM Pioneers Risk-Managed Investment, Launches Two Laddered Buffer ETFs</a></strong></p>
<p><strong>Genter Capital Dividend Income ETF</strong> targets capital and income appreciation by investing in a portfolio of mid-cap or larger companies.<strong> JPMorgan Chase </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), which has a current yield of 2.05%, holds the maximum allocation in the fund&#8217;s portfolio. <strong>M&amp;T Bank</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTB#NYSE">MTB</a>), with a dividend yield of 2.83%, also holds a significant chunk of the portfolio.</p>
<p>The net expense ratio of the ETF is 0.38%. The fund prioritizes companies with dividends eligible for capital gains tax treatment, which is good news for ETF investors looking for tax advantage. The fund also offers a covered-call strategy by selling call options on its portfolio holdings to generate additional income.</p>
<p><strong>Genter Capital International Dividend ETF </strong>targets dividend-paying companies outside the United States while maintaining a portfolio size of 25 to 50 securities. With an expense ratio of 0.40%, this ETF uses American Depository Receipts to invest in markets overseas. Exposure to U.S.-based equities is limited to up to 20%. </p>
<p>With the launch of the two ETFs, Genter Capital's ETF offerings in the U.S. comes to a tally of four. And by tapping into both domestic and international markets, these ETFs may offer a buffer from volatility in specific markets, while meeting the demand for income-generating investment methods.</p>
<p><strong>See Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/bonds/25/01/42963973/housing-demand-falls-as-average-30-year-mortgage-rate-above-7">Housing Demand Falls As Average 30-Year Mortgage Rate Above 7%</a></strong></li>
</ul>
<p><em>Photo: Shutterstock</em></p>


New ETFs

ETFs

Spinnaker ETF Series Genter Capital Dividend Income ETF

GEND

GENW

Dividend Investors Get 2 New ETF Options For 2025

Evolent Health shares are trading lower after RBC Capital cut its price target on the stock from $20 to $17.

<p><a href="https://truthsocial.com/@realDonaldTrump/posts/113827650534234057" title="https://truthsocial.com/@realDonaldTrump/posts/113827650534234057">https://truthsocial.com/@realDonaldTrump/posts/113827650534234057</a></p>


Macro Economic Events

Global

Economics

President-Elect Donald J. Trump Posts On Truth ".. I am today announcing that I will create the EXTERNAL REVENUE SERVICE to collect our Tariffs, Duties, and all Revenue that come from Foreign sources...."

<p>RBC Capital  analyst Mike Dahl   reiterates KB Home (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBH#NYSE">KBH</a>) with a Sector Perform and maintains $67 price target.</p>


Reiteration

RBC Capital Reiterates Sector Perform on KB Home, Maintains $67 Price Target

KULR

KULR Technology shares are trading higher after the company announced it signed a multi-million-dollar licensing agreement with a new technology partner to enable carbon fiber cathode applications for nuclear reactor systems in Japan.

<p>JP Morgan  analyst Tami Zakaria   maintains Terex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEX#NYSE">TEX</a>) with a Neutral and lowers the price target from $59 to $52.</p>


JP Morgan Maintains Neutral on Terex, Lowers Price Target to $52

<p>Keefe, Bruyette &amp; Woods  analyst Aidan Hall   maintains WisdomTree (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WT#NYSE">WT</a>) with a Market Perform and lowers the price target from $12 to $10.5.</p>


Keefe, Bruyette & Woods Maintains Market Perform on WisdomTree, Lowers Price Target to $10.5

NMHI

Nature's Miracle Holding shares are trading higher after the company announced it entered into a securities purchase agreement with a single institutional investor to sell up to $29.7 million in the aggregate of a newly-designated class of convertible preferred stock.

PACB

Pacific Biosciences shares are trading lower after the company issued worse-than-expected preliminary Q4 revenue.

<p>RBC Capital  analyst Sean Dodge   maintains Evolent Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVH#NYSE">EVH</a>) with a Outperform and lowers the price target from $20 to $17.</p>


RBC Capital Maintains Outperform on Evolent Health, Lowers Price Target to $17

<p>Nature's Miracle Holding, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMHI#NASDAQ">NMHI</a>) ("Nature's Miracle"), a growing agriculture technology company providing equipment and services to growers, announced that it entered into a Securities Purchase Agreement ("SPA") with a single institutional investor ("Investor") on January 10, 2025. The SPA allows Nature's Miracle, subject to customary conditions, to sell up to $29.7 million in the aggregate of a newly-designated class of convertible preferred stock to the Investor.</p>
<p>The Investor agreed to provide Nature's Miracle up to $29.7 million available in tranches. The initial tranche in the amount of $2,700,000 will be funded with $1,800,000 funded within one business day following Closing and the remaining $900,000 funded within one business day following the date on which the shares of common stock into which the shares of convertible preferred stock are convertible are registered for resale pursuant to an effective registration statement. Subsequent tranches of up to $27,000,000 may be funded in increments of up to $2,700,000 per tranche subject to certain conditions. The Investor will also receive certain warrants to purchase shares of common stock upon the funding of each tranche.</p>
<p>The funding of each subsequent tranche&nbsp;is not expected to occur earlier than 60 trading days after the funding of the prior tranche (except that the first subsequent tranche may be funded 30 trading days following the date on which the shares of common stock into which the shares of convertible preferred stock are convertible are registered for resale pursuant to an effective registration statement), in each case, subject to certain conditions including: (i) for each day of the Measurement Period, the average daily volume is greater than $500,000, (ii) for each day of the Measurement Period, the daily volume weighted average price of the Nature's Miracle's common stock is greater than $1.50, (iii) the aggregate stated value of the outstanding shares of convertible preferred stock held by the Investor is no greater than $1,000,000 (iv) the shares of common stock underlying the applicable shares of convertible preferred stock held by the Investor are registered pursuant to an effective registration statement, and (v) certain other conditions customary for a transaction of this nature. "Measurement Period" means the 20 trading days immediately preceding the applicable funding date</p>


Offerings

Reported Earlier, Nature's Miracle Holding Entered Into A Securities Purchase Agreement With A Single Institutional Investor To Sell Up To $29.7M In The Aggregate Of A Newly-Designated Class Of Convertible Preferred Stock

APLD

Applied Digital shares are trading higher after the company announced it secured a $5 billion financing facility from Macquarie Asset Management.

<p>JP Morgan  analyst Richard Shane   maintains Rocket Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RKT#NYSE">RKT</a>) with a Underweight and lowers the price target from $14 to $10.5.</p>


JP Morgan Maintains Underweight on Rocket Companies, Lowers Price Target to $10.5

<p>Whales with a lot of money to spend have taken a noticeably bearish stance on <strong>Uber Technologies</strong>.</p>
<p>Looking at options history for Uber Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) we detected 35 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 42% of the investors opened trades with bullish expectations and 48% with bearish.</p>
<p>From the overall spotted trades, 10 are puts, for a total amount of $2,413,947 and 25, calls, for a total amount of $1,992,005.</p>
<h3>Expected Price Movements</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $40.0 and $87.5 for Uber Technologies, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>In today's trading context, the average open interest for options of Uber Technologies stands at 2524.08, with a total volume reaching 26,417.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Uber Technologies, situated within the strike price corridor from $40.0 to $87.5, throughout the last 30 days.</p>
<h3>Uber Technologies 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1736872232_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>UBER</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>02/21/25</td>
<td>$0.86</td>
<td>$0.84</td>
<td>$0.85</td>
<td>$57.50</td>
<td>$1.1M</td>
<td>5.6K</td>
<td>13.7K</td>
</tr>
<tr>
<td>UBER</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$18.45</td>
<td>$18.3</td>
<td>$18.3</td>
<td>$80.00</td>
<td>$686.7K</td>
<td>625</td>
<td>31</td>
</tr>
<tr>
<td>UBER</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$15.35</td>
<td>$15.3</td>
<td>$15.35</td>
<td>$75.00</td>
<td>$251.7K</td>
<td>46</td>
<td>164</td>
</tr>
<tr>
<td>UBER</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$10.7</td>
<td>$10.6</td>
<td>$10.7</td>
<td>$62.50</td>
<td>$231.1K</td>
<td>475</td>
<td>217</td>
</tr>
<tr>
<td>UBER</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$7.55</td>
<td>$7.45</td>
<td>$7.55</td>
<td>$77.50</td>
<td>$212.1K</td>
<td>945</td>
<td>284</td>
</tr>
</tbody>
</table>
</p>
<h3>About Uber Technologies</h3>
<p>Uber Technologies is a technology provider that matches riders with drivers, hungry people with restaurants and food couriers, and shippers with carriers. The firm's on-demand technology platform is currently utilized by traditional cars as well as autonomous vehicles, but could eventually be used for additional products and services, such as delivery via drones or electronic vehicle take-off and landing technology. Uber operates in more than 70 countries, with more than 161 million users who order rides or food at least once a month.</p>
<h3>Present Market Standing of Uber Technologies</h3>
<ul>
<li>With a volume of 6,247,173, the price of UBER is down -1.07% at $65.0. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 22 days.</li>
</ul>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.</p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Uber Technologies, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

Markets

UBER

This Is What Whales Are Betting On Uber Technologies

<p>Whales with a lot of money to spend have taken a noticeably bullish stance on <strong>Newmont</strong>.</p>
<p>Looking at options history for Newmont (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>) we detected 15 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 46% of the investors opened trades with bullish expectations and 33% with bearish.</p>
<p>From the overall spotted trades, 8 are puts, for a total amount of $410,781 and 7, calls, for a total amount of $1,727,540.</p>
<h3>Predicted Price Range</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $32.5 to $55.0 for Newmont during the past quarter. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Newmont's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Newmont's substantial trades, within a strike price spectrum from $32.5 to $55.0 over the preceding 30 days.</p>
<h3>Newmont Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1736872226_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>NEM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$7.4</td>
<td>$7.25</td>
<td>$7.4</td>
<td>$37.50</td>
<td>$740.1K</td>
<td>22.1K</td>
<td>1</td>
</tr>
<tr>
<td>NEM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$7.4</td>
<td>$7.05</td>
<td>$7.35</td>
<td>$37.50</td>
<td>$737.2K</td>
<td>22.1K</td>
<td>2.0K</td>
</tr>
<tr>
<td>NEM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$0.86</td>
<td>$0.85</td>
<td>$0.86</td>
<td>$35.00</td>
<td>$102.1K</td>
<td>5.2K</td>
<td>1.1K</td>
</tr>
<tr>
<td>NEM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$1.53</td>
<td>$1.46</td>
<td>$1.53</td>
<td>$42.50</td>
<td>$81.6K</td>
<td>18.8K</td>
<td>1.0K</td>
</tr>
<tr>
<td>NEM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$16.05</td>
<td>$15.9</td>
<td>$16.0</td>
<td>$55.00</td>
<td>$79.9K</td>
<td>620</td>
<td>50</td>
</tr>
</tbody>
</table>
</p>
<h3>About Newmont</h3>
<p>Newmont is the world's largest gold miner. It bought Goldcorp in 2019, combined its Nevada mines in a joint venture with competitor Barrick later that year, and also purchased competitor Newcrest in November 2023. Its portfolio includes 17 wholly or majority owned mines and interests in two joint ventures in the Americas, Africa, Australia and Papua New Guinea. The company is expected to produce roughly 5.5 million ounces of gold in 2024 from its core mines and 6.8 million in total. It is likely to sell a number of its higher cost, smaller mines accounting for 20% of forecast sales in 2024. Newmont also produces material amounts of copper, silver, zinc, and lead as byproducts. It had about two decades of gold reserves along with significant byproduct reserves at the end of December 2023.</p>
<p>Following our analysis of the options activities associated with Newmont, we pivot to a closer look at the company's own performance.</p>
<h3>Where Is Newmont Standing Right Now?</h3>
<ul>
<li>With a volume of 2,377,025, the price of NEM is up 2.71% at $40.23. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 37 days.</li>
</ul>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.</p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Newmont options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Newmont's Options Frenzy: What You Need to Know

<p>Financial giants have made a conspicuous bullish move on EQT. Our analysis of options history for EQT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQT#NYSE">EQT</a>) revealed 20 unusual trades.</p>
<p>Delving into the details, we found 60% of traders were bullish, while 40% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $226,783, and 18 were calls, valued at $1,208,348.</p>
<h3>Expected Price Movements</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $45.0 and $65.0 for EQT, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for EQT's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of EQT's whale trades within a strike price range from $45.0 to $65.0 in the last 30 days. </p>
<h3>EQT Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1736872220_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>EQT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$3.3</td>
<td>$3.25</td>
<td>$3.3</td>
<td>$50.00</td>
<td>$334.9K</td>
<td>28.9K</td>
<td>1.6K</td>
</tr>
<tr>
<td>EQT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$6.0</td>
<td>$5.7</td>
<td>$5.9</td>
<td>$45.00</td>
<td>$176.5K</td>
<td>2.2K</td>
<td>1.0K</td>
</tr>
<tr>
<td>EQT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$14.8</td>
<td>$14.7</td>
<td>$14.8</td>
<td>$65.00</td>
<td>$127.2K</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>EQT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$14.85</td>
<td>$14.7</td>
<td>$14.85</td>
<td>$65.00</td>
<td>$99.4K</td>
<td>0</td>
<td>87</td>
</tr>
<tr>
<td>EQT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$6.0</td>
<td>$5.9</td>
<td>$6.0</td>
<td>$45.00</td>
<td>$99.0K</td>
<td>2.2K</td>
<td>553</td>
</tr>
</tbody>
</table>
</p>
<h3>About EQT</h3>
<p>EQT Corp is an independent natural gas production company with operations focused in the Marcellus and Utica shale plays in the Appalachian Basin. At year-end 2023, EQT's proven reserves totaled 27.6 trillion cubic feet equivalent, with net production of 5.79 billion cubic feet equivalent per day. Natural gas accounted for 94% of production.</p>
<p>Having examined the options trading patterns of EQT, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>EQT's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 2,299,978, the EQT's price is up by 1.28%, now at $50.72. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 35 days.</li>
</ul>
<h3>Expert Opinions on EQT</h3>
<p>Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $54.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Mizuho upgraded its action to Outperform with a price target of $57.<br />
&#x2A; An analyst from RBC Capital downgraded its action to Sector Perform with a price target of $49.<br />
&#x2A; An analyst from Truist Securities persists with their Hold rating on EQT, maintaining a target price of $56.<br />
&#x2A; Consistent in their evaluation, an analyst from JP Morgan keeps a Overweight rating on EQT with a target price of $53.<br />
&#x2A; Consistent in their evaluation, an analyst from Jefferies keeps a Buy rating on EQT with a target price of $55. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest EQT options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Smart Money Is Betting Big In EQT Options

<p>Keefe, Bruyette &amp; Woods  analyst Jade Rahmani   maintains Starwood Prop Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STWD#NYSE">STWD</a>) with a Outperform and lowers the price target from $22.5 to $22.</p>


Comments

iShares Trust iShares Large Cap Max Buffer Jun ETF

News

Latest news for iShares Trust iShares Large Cap Max Buffer Jun ETF (BATS:MAXJ)

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga